Dr. Sara Naseri: Menstrual blood as a diagnostic tool
1 big thing7 Mars 2024

Dr. Sara Naseri: Menstrual blood as a diagnostic tool

It's estimated only one percent of medical research spending globally goes toward female-specific conditions that aren't related to cancer. But even as underfunding of women's health persists -- companies focused on women's health are innovating. Dr. Sara Naseri is working to reframe menstrual blood as a diagnostic tool rather than waste, with her company called Qvin. It received FDA clearance in January of this year for a new kind of blood test: a diagnostic menstrual pad. Plus, Axios senior health care editor Adriel Bettelheim on innovations in women's health. Guests: Dr. Sara Naseri, CEO and co-founder of Qvin; Axios' Adriel Bettelheim Credits: 1 big thing is produced by Niala Boodhoo, Alexandra Botti, and Jay Cowit. Music is composed by Alex Sugiura and Jay Cowit. You can reach us at podcasts@axios.com. You can send questions, comments and story ideas as a text or voice memo to Niala at 202-918-4893.

Avsnitt(881)

Biden, Manchin, and climate change

Biden, Manchin, and climate change

There was lots of news over the weekend about West Virginia Senator Joe Manchin’s opposition to a crucial piece of President Biden's proposed climate agenda. That piece would encourage wind, solar, an...

18 Okt 202111min

The Hard Truth of facial recognition technology

The Hard Truth of facial recognition technology

On our latest installment of our Hard Truths series, we look at how faulty technology is making its way into the U.S. immigration system. Guests: Chaz Arnett, law professor at the University of Maryla...

16 Okt 202114min

The bad and the good in the latest inflation data

The bad and the good in the latest inflation data

The global energy crisis is causing a whole series of economic headaches, not the least of which is inflation. The Consumer Price Index, the best American measure of inflation, jumped 5.4% in Septembe...

15 Okt 202111min

Clearing up the latest confusion around boosters

Clearing up the latest confusion around boosters

New data from the National Institutes of Health shows that people who got the Johnson & Johnson vaccine might benefit from getting a Pfizer or Moderna booster shot. But J&J has asked the FDA to approv...

14 Okt 202111min

The economic fallout from rude customers

The economic fallout from rude customers

A recent survey of more than 13,000 workers found that 58% of restaurant and hotel employees plan to quit their jobs by the end of this year. And more than a third of them are citing difficult custome...

13 Okt 202111min

Big Tech’s Big Tobacco moment

Big Tech’s Big Tobacco moment

Senators at Facebook’s hearing last week used an analogy we’ve heard before -- that Big Tech is having its Big Tobacco moment. But: It took decades to enact meaningful regulations with Big Tobacco, an...

12 Okt 202111min

The forecast for holiday travel doesn’t look good

The forecast for holiday travel doesn’t look good

Over the weekend, Southwest Airlines cancelled nearly 2,000 of their flights citing weather and air traffic control issues. And while the Federal Aviation Administration confirmed staffing shortages i...

11 Okt 202111min

Averting default for now

Averting default for now

After days of will-they, won’t-they on the Hill, Senate Democrats and Republicans came to an agreement yesterday to extend the debt ceiling through early December. This came less than two weeks ahead ...

8 Okt 202111min

Populärt inom Politik & nyheter

motiv
aftonbladet-krim
rss-krimstad
p3-krim
fordomspodden
flashback-forever
spar
aftonbladet-daily
rss-viva-fotboll
blenda-2
rss-sanning-konsekvens
svenska-fall
rss-krimreportrarna
rss-frandfors-horna
rss-vad-fan-hande
olyckan-inifran
rss-flodet
rss-expressen-dok
dagens-eko
svd-dokumentara-berattelser-2